Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) Director Stephen Steinour bought 6,700 shares of the business’s stock in a transaction on Friday, November 21st. The stock was purchased at an average price of $14.86 per share, for a total transaction of $99,562.00. Following the purchase, the director directly owned 48,175 shares in the company, valued at approximately $715,880.50. This represents a 16.15% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Bath & Body Works Price Performance
Shares of BBWI traded up $0.73 during mid-day trading on Monday, hitting $15.58. 18,349,612 shares of the company’s stock were exchanged, compared to its average volume of 5,908,003. Bath & Body Works, Inc. has a 52 week low of $14.27 and a 52 week high of $41.87. The company has a market cap of $3.21 billion, a PE ratio of 4.62, a P/E/G ratio of 0.86 and a beta of 1.53. The company has a 50-day simple moving average of $24.58 and a 200 day simple moving average of $28.11.
Bath & Body Works (NYSE:BBWI – Get Free Report) last announced its earnings results on Thursday, November 20th. The company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.40 by ($0.05). The business had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.64 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The business’s revenue for the quarter was down 1.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.49 EPS. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS. Q4 2025 guidance at 1.700- EPS. On average, analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.
Bath & Body Works Announces Dividend
Wall Street Analyst Weigh In
Several brokerages recently commented on BBWI. Morgan Stanley reissued an “equal weight” rating and set a $18.00 price target (down from $43.00) on shares of Bath & Body Works in a research report on Friday. Robert W. Baird reissued a “neutral” rating and issued a $19.00 target price (down from $33.00) on shares of Bath & Body Works in a research note on Thursday. Baird R W lowered shares of Bath & Body Works from a “strong-buy” rating to a “hold” rating in a research report on Friday. UBS Group cut their price target on shares of Bath & Body Works from $32.00 to $17.00 and set a “neutral” rating for the company in a research note on Friday. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Bath & Body Works in a research note on Wednesday, October 8th. Seven investment analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $26.84.
Read Our Latest Stock Analysis on BBWI
Institutional Trading of Bath & Body Works
Several hedge funds and other institutional investors have recently modified their holdings of BBWI. Danske Bank A S acquired a new position in Bath & Body Works in the 3rd quarter valued at about $39,000. Advisory Services Network LLC bought a new stake in shares of Bath & Body Works during the third quarter worth approximately $48,000. Dark Forest Capital Management LP grew its position in shares of Bath & Body Works by 91.3% in the third quarter. Dark Forest Capital Management LP now owns 101,662 shares of the company’s stock valued at $2,619,000 after purchasing an additional 48,525 shares during the last quarter. XTX Topco Ltd bought a new position in shares of Bath & Body Works during the third quarter worth approximately $1,256,000. Finally, United Capital Financial Advisors LLC acquired a new stake in Bath & Body Works during the 3rd quarter worth approximately $263,000. Institutional investors own 95.14% of the company’s stock.
About Bath & Body Works
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Recommended Stories
- Five stocks we like better than Bath & Body Works
- How to trade using analyst ratings
- Hims, Block, and NRG Just Launched Huge Stock Buybacks
- Options Trading – Understanding Strike Price
- Retail Earnings Roundup: Walmart Scores, Target Slumps in Q3
- Insider Trading – What You Need to Know
- JPMorgan and Goldman Upgrade MP Materials Amid Defense-Driven Demand Outlook
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
